Cash flow Akzo Nobel N.V.

Stocks

AKZA

NL0013267909

Commodity Chemicals

Market Closed - Euronext Amsterdam Other stock markets 11:55:00 2026-06-15 am EDT			After hours 02:19:53 pm
58.90 ^EUR	+1.94%		58.75	-0.25%

Jun. 08	AKZO NOBEL NV : Goldman Sachs gives a Neutral rating	ZD
Jun. 04	AlphaValue/Baader Europe Upgrades Akzo Nobel to Add, Trims PT	MT

003d68b1355.yoh9HW1kLE19WhrF-WI1-kOgoB8shH9XiSP9jcDb-o0._c5LbSYzSDxOCGu0jDFhyHr0yHFr_C1i4FXM_LmPv-m8_hpqNANOLjU9Qw

Published financial data: AKZO NOBEL N.V.

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2021	2022	2023	2024	2025
Revenues	9.59B	10.85B	10.67B	10.71B	10.16B
Total Revenues	9.59B	10.85B	10.67B	10.71B	10.16B
Cost of Goods Sold, Total	5.73B	6.92B	6.43B	6.37B	6.11B
Gross Profit	3.86B	3.92B	4.23B	4.34B	4.05B
Selling General & Admin Expenses, Total	2.56B	2.94B	2.96B	3.09B	2.97B
R&D Expenses	230M	258M	270M	296M	274M
Other Operating Expenses	-25M	-	-60M	6M	-7M
Other Operating Expenses, Total	2.77B	3.2B	3.17B	3.39B	3.24B
Operating Income	1.09B	726M	1.06B	944M	813M
Interest Expense, Total	-74M	-106M	-193M	-190M	-211M
Interest And Investment Income	12M	36M	69M	61M	49M
Net Interest Expenses	-62M	-70M	-124M	-129M	-162M
Income (Loss) On Equity Invest.	26M	18M	27M	23M	33M
Currency Exchange Gains (Loss)	-	-85M	-128M	-47M	-49M
Other Non Operating Income (Expenses)	-18M	13M	-7M	32M	6M
EBT, Excl. Unusual Items	1.04B	602M	830M	823M	641M
Merger & Related Restructuring Charges	-	-	-	-	-
Gain (Loss) On Sale Of Assets	-	-	-	-	655M
Asset Writedown	-	-	-	-	-
Legal Settlements	70M	-	-	-	-272M
Other Unusual Items	-	-	-46M	15M	-26M
EBT, Incl. Unusual Items	1.1B	602M	784M	838M	998M
Income Tax Expense	246M	214M	296M	246M	326M
Earnings From Continuing Operations	859M	388M	488M	592M	672M
Earnings Of Discontinued Operations	6M	-10M	-5M	-	-1M
Net Income to Company	865M	378M	483M	592M	671M
Minority Interest	-36M	-26M	-41M	-50M	-36M
Net Income - (IS)	829M	352M	442M	542M	635M
Net Income to Common Incl Extra Items	829M	352M	442M	542M	635M
Net Income to Common Excl. Extra Items	823M	362M	447M	542M	636M
Per Share Items
Net EPS - Basic	4.48	2.01	2.59	3.17	3.71
Basic EPS - Continuing Operations	4.45	2.07	2.62	3.17	3.72
Basic Weighted Average Shares Outstanding	185M	175M	171M	171M	171M
Net EPS - Diluted	4.46	2	2.58	3.16	3.69
Diluted EPS - Continuing Operations	4.43	2.06	2.61	3.16	3.7
Diluted Weighted Average Shares Outstanding	186M	175M	171M	172M	172M
Normalized Basic EPS	3.3	2	2.8	2.72	2.13
Normalized Diluted EPS	3.29	2	2.79	2.71	2.12
Dividend Per Share	1.98	1.98	1.98	1.98	1.98
Payout Ratio	43.91	107.67	83.26	62.36	53.39
American Depositary Receipts Ratio (ADR)	0.33	0.33	0.33	0.33	0.33
Supplemental Items
EBITDA	1.35B	996M	1.32B	1.22B	1.09B
EBITA	1.16B	813M	1.14B	1.02B	891M
EBIT	1.09B	726M	1.06B	944M	813M
EBITDAR	1.36B	1.01B	1.34B	1.24B	1.13B
Effective Tax Rate - (Ratio)	22.26	35.55	37.76	29.36	32.67
Total Current Taxes	169M	222M	305M	197M	324M
Total Deferred Taxes	77M	-8M	-9M	49M	2M
Normalized Net Income	611M	350M	478M	464M	365M
Interest Capitalized	-	-	-	-	-
Interest on Long-Term Debt	6M	6M	7M	9M	10M
Non-Cash Pension Expense	-35M	-18M	-32M	-26M	-22M
Supplemental Operating Expense Items
Selling and Marketing Expenses	1.99B	2.31B	2.35B	2.46B	2.35B
General and Administrative Expenses	582M	649M	648M	655M	649M
Research And Development Expense From Footnotes	230M	258M	270M	296M	274M
Net Rental Expense, Total	14M	17M	21M	21M	38M
Imputed Operating Lease Interest Expense	2.57M	3.06M	5.67M	5.84M	12.54M
Imputed Operating Lease Depreciation	11.43M	13.94M	15.33M	15.16M	25.46M
Stock-Based Comp., Other (Total)	18M	16M	18M	23M	24M
Total Stock-Based Compensation	18M	16M	18M	23M	24M

Fiscal Period: December	2021	2022	2023	2024	2025
Assets
Cash And Equivalents	1.15B	1.45B	1.51B	1.3B	1.62B
Short Term Investments	58M	336M	265M	165M	302M
Total Cash And Short Term Investments	1.21B	1.79B	1.78B	1.47B	1.92B
Accounts Receivable, Total	1.98B	2.12B	2.19B	2.14B	1.99B
Other Receivables	454M	416M	377M	446M	571M
Total Receivables	2.44B	2.54B	2.56B	2.59B	2.56B
Inventory	1.65B	1.84B	1.65B	1.72B	1.53B
Prepaid Expenses	37M	58M	39M	42M	35M
Other Current Assets, Total	15M	18M	14M	16M	16M
Total Current Assets	5.35B	6.24B	6.04B	5.84B	6.06B
Gross Property Plant And Equipment	5.44B	5.75B	5.83B	6.11B	5.86B
Accumulated Depreciation	-3.34B	-3.49B	-3.54B	-3.67B	-3.53B
Net Property Plant And Equipment	2.1B	2.26B	2.3B	2.44B	2.33B
Long-term Investments	178M	193M	216M	228M	232M
Goodwill	1.16B	1.38B	1.43B	1.44B	1.39B
Other Intangibles, Total	2.54B	2.7B	2.65B	2.61B	2.41B
Loans Receivable Long-Term	88M	89M	89M	91M	57M
Deferred Tax Assets Long-Term	482M	498M	512M	422M	401M
Other Long-Term Assets, Total	1.99B	1.39B	1.32B	1.18B	1.07B
Total Assets	13.88B	14.74B	14.56B	14.25B	13.95B
Liabilities
Accounts Payable, Total	2.38B	2.21B	2.31B	2.22B	2.16B
Accrued Expenses, Total	540M	516M	598M	507M	543M
Short-term Borrowings	715M	2.46B	1.64B	1.52B	526M
Current Portion of Long-Term Debt	754M	2M	671M	87M	586M
Current Portion of Leases	87M	86M	89M	91M	80M
Current Income Taxes Payable	216M	236M	211M	120M	139M
Other Current Liabilities	181M	245M	187M	186M	176M
Total Current Liabilities	4.87B	5.75B	5.71B	4.73B	4.21B
Long-Term Debt	1.78B	3.13B	2.97B	3.47B	3.48B
Long-Term Leases	212M	198M	194M	201M	194M
Pension & Other Post Retirement Benefits	578M	387M	423M	381M	300M
Deferred Tax Liability Non Current	567M	561M	557M	491M	487M
Other Non Current Liabilities	234M	167M	161M	160M	466M
Total Liabilities	8.24B	10.19B	10.01B	9.43B	9.13B
Common Stock, Total	91M	87M	85M	85M	86M
Additional Paid In Capital	-	-	-	-	-
Retained Earnings	5.85B	4.94B	679M	786M	871M
Comprehensive Income and Other	-512M	-693M	3.56B	3.7B	3.7B
Total Common Equity	5.42B	4.33B	4.32B	4.57B	4.66B
Minority Interest	211M	215M	224M	242M	163M
Total Equity	5.64B	4.55B	4.55B	4.82B	4.82B
Total Liabilities And Equity	13.88B	14.74B	14.56B	14.25B	13.95B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	179M	170M	171M	171M	171M
ECS Total Common Shares Outstanding	179M	170M	171M	171M	171M
Book Value / Share	30.33	25.42	25.33	26.78	27.23
Tangible Book Value	1.74B	261M	241M	525M	861M
Tangible Book Value Per Share	9.7	1.53	1.41	3.07	5.03
Total Debt	3.55B	5.88B	5.56B	5.37B	4.86B
Net Debt	2.34B	4.09B	3.78B	3.9B	2.94B
Debt Equivalent of Unfunded Proj. Benefit Obligation	-1.15B	-718M	-659M	-616M	-633M
Debt Equivalent Oper. Leases	112M	136M	168M	168M	304M
Minority Interest, Total (Incl. Fin. Div)	211M	215M	224M	242M	163M
Equity Method Investments, Total	178M	193M	216M	228M	232M
Account Code - Inventory Valuation	6	6	6	6	6
Inventories - Raw Materials, Total	611M	676M	579M	601M	507M
Inventories - Work In Process, Total	94M	104M	91M	101M	87M
Inventories - Finished Goods, Total	945M	1.06B	979M	1.02B	935M
Land - (BS)	-	-	-	1.74B	1.68B
Buildings, Total	1.55B	1.66B	1.66B	-	-
Machinery, Total	3.04B	3.13B	3.21B	3.37B	3.26B
Full Time Employees	32.8K	35.2K	33.96K	33.75K	30.7K
Part Time Employees	-	-	1.61K	1.58K	1.47K
Accumulated Allowance for Doubtful Accounts (Supple)	42M	42M	39M	34M	28M

Fiscal Period: December	2021	2022	2023	2024	2025
Net Income	829M	352M	442M	542M	635M
Depreciation & Amortization - CF	281M	281M	277M	293M	300M
Amortization of Goodwill and Intangible Assets - (CF)	70M	87M	80M	78M	78M
Depreciation & Amortization, Total	351M	368M	357M	371M	378M
Asset Writedown & Restructuring Costs	3M	6M	4M	-	9M
(Income) Loss On Equity Investments - (CF)	-26M	-18M	-27M	-23M	-33M
Net Cash From Discontinued Operations	-1M	-9M	-6M	-5M	-1M
Other Operating Activities, Total	2M	128M	149M	-18M	-527M
Change In Accounts Receivable	-240M	-95M	-111M	12M	-50M
Change In Inventories	-439M	-134M	131M	-83M	49M
Change In Accounts Payable	274M	-280M	234M	-135M	167M
Change in Other Net Operating Assets	-149M	-64M	-53M	7M	287M
Cash from Operations	604M	254M	1.12B	668M	914M
Capital Expenditure	-288M	-292M	-286M	-306M	-309M
Cash Acquisitions	-73M	-588M	-114M	2M	-
Divestitures	22M	36M	96M	1M	816M
Investment in Marketable and Equity Securities, Total	191M	-277M	78M	103M	-140M
Other Investing Activities, Total	14M	26M	82M	68M	75M
Cash from Investing	-134M	-1.1B	-144M	-132M	442M
Long-Term Debt Issued, Total	1.14B	9.51B	5.84B	2.81B	2.45B
Total Debt Issued	1.14B	9.51B	5.84B	2.81B	2.45B
Long-Term Debt Repaid, Total	-590M	-7.32B	-6.3B	-3.1B	-3.04B
Total Debt Repaid	-590M	-7.32B	-6.3B	-3.1B	-3.04B
Repurchase of Common Stock	-1.14B	-669M	-	-	-
Common Dividends Paid	-364M	-379M	-368M	-338M	-339M
Common & Preferred Stock Dividends Paid	-364M	-379M	-368M	-338M	-339M
Special Dividend Paid	-	-	-	-	-
Other Financing Activities, Total	-28M	-	-	-51M	-60M
Cash from Financing	-974M	1.14B	-827M	-684M	-981M
Foreign Exchange Rate Adjustments	35M	-14M	-94M	-32M	-43M
Net Change in Cash	-469M	286M	55M	-180M	332M
Supplemental Items
Cash Interest Paid	77M	78M	167M	174M	162M
Cash Income Tax Paid (Refund)	222M	224M	295M	291M	268M
Levered Free Cash Flow	124M	49.5M	929M	181M	679M
Unlevered Free Cash Flow	171M	116M	1.05B	300M	811M
Change In Net Working Capital	591M	430M	-297M	378M	-210M
Net Debt Issued / Repaid	553M	2.19B	-459M	-295M	-582M

Fiscal Period: December	2021	2022	2023	2024	2025
Profitability
Return on Assets	5.03	3.17	4.53	4.1	3.6
Return on Total Capital	7.55	4.63	6.47	5.81	5.12
Return On Equity %	14.83	7.62	10.73	12.65	13.94
Return on Common Equity	14.73	7.42	10.33	12.19	13.78
Margin Analysis
Gross Profit Margin %	40.21	36.17	39.69	40.49	39.86
SG&A Margin	26.71	27.1	27.77	28.86	29.23
EBITDA Margin %	14.04	9.18	12.37	11.34	10.71
EBITA Margin %	12.09	7.5	10.7	9.54	8.77
EBIT Margin %	11.36	6.69	9.96	8.81	8
Income From Continuing Operations Margin %	8.96	3.58	4.57	5.53	6.62
Net Income Margin %	8.65	3.25	4.14	5.06	6.25
Net Avail. For Common Margin %	8.58	3.34	4.19	5.06	6.26
Normalized Net Income Margin	6.37	3.23	4.48	4.34	3.59
Levered Free Cash Flow Margin	1.3	0.46	8.71	1.69	6.69
Unlevered Free Cash Flow Margin	1.78	1.07	9.84	2.8	7.98
Asset Turnover
Asset Turnover	0.71	0.76	0.73	0.74	0.72
Fixed Assets Turnover	4.74	4.97	4.68	4.52	4.26
Receivables Turnover (Average Receivables)	5.14	5.3	4.95	4.95	4.91
Inventory Turnover (Average Inventory)	4.08	3.96	3.68	3.78	3.76
Short Term Liquidity
Current Ratio	1.1	1.09	1.06	1.23	1.44
Quick Ratio	0.75	0.75	0.76	0.86	1.07
Operating Cash Flow to Current Liabilities	0.12	0.04	0.2	0.14	0.22
Days Sales Outstanding (Average Receivables)	71.06	68.92	73.73	74	74.27
Days Outstanding Inventory (Average Inventory)	89.43	92.08	99.05	96.75	97.09
Average Days Payable Outstanding	129.27	117.51	132.14	128.66	135
Cash Conversion Cycle (Average Days)	31.22	43.49	40.64	42.09	36.36
Long Term Solvency
Total Debt/Equity	62.99	129.18	122.37	111.46	100.83
Total Debt / Total Capital	38.65	56.37	55.03	52.71	50.21
LT Debt/Equity	35.38	73.26	69.62	76.22	76.11
Long-Term Debt / Total Capital	21.71	31.97	31.31	36.05	37.9
Total Liabilities / Total Assets	59.39	69.15	68.77	66.2	65.44
EBIT / Interest Expense	14.72	6.85	5.5	4.97	3.85
EBITDA / Interest Expense	19.46	10.32	7.35	6.92	5.64
(EBITDA - Capex) / Interest Expense	15.57	7.57	5.87	5.31	4.18
Total Debt / EBITDA	2.47	5.37	3.92	4.08	4.08
Net Debt / EBITDA	1.62	3.74	2.67	2.97	2.47
Total Debt / (EBITDA - Capex)	3.08	7.33	4.91	5.32	5.51
Net Debt / (EBITDA - Capex)	2.03	5.1	3.34	3.87	3.34
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	12.39	13.13	-1.64	0.4	-5.16
Gross Profit, 1 Yr. Growth %	1.85	0.49	7.93	2.43	-6.64
EBITDA, 1 Yr. Growth %	9.88	-26	32.53	-7.95	-10.45
EBITA, 1 Yr. Growth %	12.85	-29.85	40.47	-10.51	-12.82
EBIT, 1 Yr. Growth %	13.08	-33.33	46.28	-11.11	-13.88
Earnings From Cont. Operations, 1 Yr. Growth %	26.7	-54.83	25.77	21.31	13.51
Net Income, 1 Yr. Growth %	31.59	-57.54	25.57	22.62	17.16
Normalized Net Income, 1 Yr. Growth %	14.53	-42.66	31.7	-2.8	-21.48
Diluted EPS Before Extra, 1 Yr. Growth %	33.43	-53.5	26.7	21.07	17.09
Accounts Receivable, 1 Yr. Growth %	13.19	7.6	3.01	-1.97	-7.18
Inventory, 1 Yr. Growth %	42.36	11.7	-10.53	4.37	-11.16
Net Property, Plant and Equip., 1 Yr. Growth %	8.17	7.37	1.64	6.27	-4.39
Total Assets, 1 Yr. Growth %	5.32	6.22	-1.24	-2.12	-2.08
Tangible Book Value, 1 Yr. Growth %	-20.85	-84.96	-7.66	117.84	64
Common Equity, 1 Yr. Growth %	-5.59	-20.13	-0.25	5.83	1.86
Cash From Operations, 1 Yr. Growth %	-50.37	-57.95	340.94	-40.36	36.83
Capital Expenditures, 1 Yr. Growth %	11.63	1.39	-2.05	6.99	0.98
Levered Free Cash Flow, 1 Yr. Growth %	-86.88	-60.2	1.78K	-80.49	274.76
Unlevered Free Cash Flow, 1 Yr. Growth %	-82.71	-32.16	806.91	-71.42	170.38
Dividend Per Share, 1 Yr. Growth %	1.54	0	0	0	0
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	1.66	12.76	5.49	-0.62	-2.42
Gross Profit, 2 Yr. CAGR %	-1.36	1.81	4.14	5.14	-2.21
EBITDA, 2 Yr. CAGR %	9.77	-9.83	-0.97	10.45	-9.21
EBITA, 2 Yr. CAGR %	11.7	-11.03	-0.74	12.12	-11.67
EBIT, 2 Yr. CAGR %	12.4	-13.17	-1.25	14.03	-12.51
Earnings From Cont. Operations, 2 Yr. CAGR %	24.41	-24.35	-24.63	23.52	17.35
Net Income, 2 Yr. CAGR %	24.02	-25.25	-26.98	24.09	19.86
Normalized Net Income, 2 Yr. CAGR %	16.17	-18.96	-11.57	13.14	-12.64
Diluted EPS Before Extra, 2 Yr. CAGR %	35.3	-21.23	-23.24	23.85	19.06
Accounts Receivable, 2 Yr. CAGR %	4.59	10.11	5.28	0.49	-4.61
Inventory, 2 Yr. CAGR %	20.36	26.1	-0.03	-3.37	-3.71
Net Property, Plant and Equip., 2 Yr. CAGR %	0.72	7.77	4.46	3.93	0.8
Total Assets, 2 Yr. CAGR %	3.39	5.77	2.42	-1.68	-2.1
Tangible Book Value, 2 Yr. CAGR %	-20.21	-65.49	-62.73	41.83	89.01
Common Equity, 2 Yr. CAGR %	-7.57	-13.16	-10.74	2.74	3.83
Cash From Operations, 2 Yr. CAGR %	412.45	-54.32	36.17	62.17	-9.66
Capital Expenditures, 2 Yr. CAGR %	16.01	6.39	-0.35	2.37	3.94
Levered Free Cash Flow, 2 Yr. CAGR %	-45.29	-77.15	173.32	91.35	-14.5
Unlevered Free Cash Flow, 2 Yr. CAGR %	-39.86	-65.75	148.04	60.99	-12.1
Dividend Per Share, 2 Yr. CAGR %	2.08	0.77	0	0	0
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	1.18	5.35	7.74	3.76	-2.16
Gross Profit, 3 Yr. CAGR %	-0.61	-0.33	3.81	3.57	1.06
EBITDA, 3 Yr. CAGR %	16.38	-3.75	2.52	-3.36	2.99
EBITA, 3 Yr. CAGR %	19.86	-4.35	3.6	-4.11	3.1
EBIT, 3 Yr. CAGR %	20.98	-5.56	3.32	-4.65	3.84
Earnings From Cont. Operations, 3 Yr. CAGR %	23.59	-11.25	-10.38	-11.67	20.09
Net Income, 3 Yr. CAGR %	-50.11	-13.24	-11.14	-13.21	21.73
Normalized Net Income, 3 Yr. CAGR %	27.82	-8.19	-3.6	-8.73	0.17
Diluted EPS Before Extra, 3 Yr. CAGR %	36.18	-5.23	-7.71	-10.65	21.56
Accounts Receivable, 3 Yr. CAGR %	2.45	5.42	7.69	2.81	-2.13
Inventory, 3 Yr. CAGR %	13.15	17.4	12.47	1.41	-6.04
Net Property, Plant and Equip., 3 Yr. CAGR %	6.37	2.89	5.69	5.06	1.08
Total Assets, 3 Yr. CAGR %	-9.6	4.32	3.38	0.88	-1.82
Tangible Book Value, 3 Yr. CAGR %	-40.83	-54.25	-52.09	-32.86	48.86
Common Equity, 3 Yr. CAGR %	-22.89	-11.96	-9.06	-5.53	2.45
Cash From Operations, 3 Yr. CAGR %	5.59	122.69	-2.73	3.41	53.24
Capital Expenditures, 3 Yr. CAGR %	16.11	10.91	3.49	2.04	1.9
Levered Free Cash Flow, 3 Yr. CAGR %	-63.21	-50.79	-0.67	13.37	139.41
Unlevered Free Cash Flow, 3 Yr. CAGR %	-59.44	-37.4	2.08	20.7	91.36
Dividend Per Share, 3 Yr. CAGR %	2.36	1.38	0.51	0	0
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	0.32	2.45	2.88	2.92	3.56
Gross Profit, 5 Yr. CAGR %	-2.32	-1.51	1.52	1.83	1.36
EBITDA, 5 Yr. CAGR %	2.14	-1.86	9.1	1.7	-2.34
EBITA, 5 Yr. CAGR %	2.89	-0.12	11.16	1.93	-2.8
EBIT, 5 Yr. CAGR %	3.23	-2.36	11.54	1.83	-3.33
Earnings From Cont. Operations, 5 Yr. CAGR %	6.88	-5.36	1.41	1.3	-0.18
Net Income, 5 Yr. CAGR %	-3.09	-15.81	-41.9	0.11	0.16
Normalized Net Income, 5 Yr. CAGR %	6.34	-2.89	10.31	0.51	-7.32
Diluted EPS Before Extra, 5 Yr. CAGR %	13.19	1.04	8.27	5.48	2.19
Accounts Receivable, 5 Yr. CAGR %	-2.69	4.54	3.48	3.42	2.59
Inventory, 5 Yr. CAGR %	1.5	10.99	7.68	8.61	5.7
Net Property, Plant and Equip., 5 Yr. CAGR %	-12.87	4.28	5.61	3.3	3.7
Total Assets, 5 Yr. CAGR %	-3.04	-1.84	-4.97	1.88	1.15
Tangible Book Value, 5 Yr. CAGR %	-4.11	-36.13	-50.82	-28.06	-17.05
Common Equity, 5 Yr. CAGR %	-3.71	-5.88	-18.25	-6.35	-4.11
Cash From Operations, 5 Yr. CAGR %	-14.09	-23.49	16.9	96.16	-5.57
Capital Expenditures, 5 Yr. CAGR %	-14.6	3.15	9.22	7.41	3.67
Levered Free Cash Flow, 5 Yr. CAGR %	15.03	-50.27	-17.95	-15.29	-6.45
Unlevered Free Cash Flow, 5 Yr. CAGR %	4.24	-40.57	-16.31	-8.66	-3.85
Dividend Per Share, 5 Yr. CAGR %	1.3	-6.78	1.41	0.83	0.31